Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

JAK2 fusion

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

CRLF2 rearrangement + JAK2 fusion (1)

HMGA1 deletion+ JAK2 V617F (1)

IGH-CRLF2 fusion + JAK2 GPInsR683 (1)

IGH-CRLF2 fusion + JAK2 R867Q (1)

IGH-CRLF2 fusion + JAK2 R683G (1)

JAK2 mutation + MSI-H/dMMR (1)

P2RY8-CRLF2 fusion + JAK2 QGinsR683 (1)

PD-L1 expression + JAK2 mutation (1)

PD-L1 expression + STK11 mutation + JAK2 mutation (1)

RNPC3‐JAK2 fusion + Chr t(1;9)(p13;p22) (1)

HMGA1 deletion+ JAK2 V617 (0)

CRLF2 rearrangement + JAK2 fusion (1)

HMGA1 deletion+ JAK2 V617F (1)

IGH-CRLF2 fusion + JAK2 GPInsR683 (1)

IGH-CRLF2 fusion + JAK2 R867Q (1)

IGH-CRLF2 fusion + JAK2 R683G (1)

JAK2 mutation + MSI-H/dMMR (1)

P2RY8-CRLF2 fusion + JAK2 QGinsR683 (1)

PD-L1 expression + JAK2 mutation (1)

PD-L1 expression + STK11 mutation + JAK2 mutation (1)

RNPC3‐JAK2 fusion + Chr t(1;9)(p13;p22) (1)

HMGA1 deletion+ JAK2 V617 (0)

›

Childhood B Acute Lymphoblastic Leukemia

Sensitive: A2 - Guideline

Sensitive: A2 - Guideline